Ranbaxy Laboratories to acquire product rights and manufacturing facility from Biovel Life Sciences - MarketLine Financial Deals

Ranbaxy Laboratories to acquire product rights and manufacturing facility from Biovel Life Sciences

Ranbaxy Laboratories to acquire product rights and manufacturing facility from Biovel Life Sciences - MarketLine Financial Deals
Ranbaxy Laboratories to acquire product rights and manufacturing facility from Biovel Life Sciences
Published Jan 19, 2010
2 pages — Published Jan 19, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Ranbaxy Laboratories Limited has singed an agreement to acquire product rights and manufacturing facility located in Bangalore, India from Biovel Life Sciences Pvt. Limited.

  
Source:
Document ID
MA17581_100122
Country
Ticker
500359=IN
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Ranbaxy Laboratories to acquire product rights and manufacturing facility from Biovel Life Sciences" Jan 19, 2010. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ranbaxy-Laboratories-to-acquire-product-rights-and-manufacturing-facility-from-Biovel-Life-Sciences-2052-22290>
  
APA:
MarketLine Financial Deals. (2010). Ranbaxy Laboratories to acquire product rights and manufacturing facility from Biovel Life Sciences Jan 19, 2010. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ranbaxy-Laboratories-to-acquire-product-rights-and-manufacturing-facility-from-Biovel-Life-Sciences-2052-22290>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.